Secondary Hypothyroidism When Initial Levothyroxine Did Not Normalize TSH
This protocol addresses patients with secondary hypothyroidism who were started on levothyroxine but whose thyroid-stimulating hormone (TSH) level remained outside the normal range at the six- to eight-week recheck.
The first-line regimen — Levothyroxine — did not achieve the target: a TSH level within the normal range (0.4 to 4.5 mIU per L) when retested at six to eight weeks. That unmet goal is the defined trigger for this next-line protocol.
The next step involves reassessing adherence and potential drug interactions, followed by a structured, direction-guided adjustment to the levothyroxine dosage. The specific decision rules, thresholds, and monitoring schedule are contained in the full protocol.
The clinical target remains a TSH level within the normal range (0.4 to 4.5 mIU per L).
References
- If the TSH level is abnormal, the clinician should assess patient adherence, evaluate drug-drug interactions, and adjust the levothyroxine dosage every six to eight weeks until the TSH level normalizes (Figure 2).
- When TSH is low (over-replacement), the daily dosage should be decreased by 12.5 to 25 mcg.
- When TSH is high (under-replacement), the daily dosage is increased by 12.5 to 25 mcg per day.